Angiodynamics (ANGO) Other Operating Expenses (2010 - 2026)

Angiodynamics (ANGO) has 17 years of Other Operating Expenses data on file, last reported at $30.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses changed N/A year-over-year to $30.1 million; the trailing twelve-month figure through Feb 2026 stood at $90.2 million (changed N/A YoY), and the FY2024 full-year result was $54.5 million, changed N/A from the prior year.
• Other Operating Expenses for Q1 2026 stood at $30.1 million, up from $29.4 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $47.8 million in Q3 2023 and bottomed at $6.7 million in Q1 2024.
• The 5-year median for Other Operating Expenses is $30.1 million (2026), against an average of $28.9 million.
• Peak annual rise in Other Operating Expenses reached 11.92% in 2022, while the deepest fall reached 5.94% in 2022.
• A 5-year view of Other Operating Expenses shows it stood at $31.9 million in 2022, then jumped by 50.01% to $47.8 million in 2023, then tumbled by 86.09% to $6.7 million in 2024, then jumped by 340.95% to $29.4 million in 2025, then climbed by 2.56% to $30.1 million in 2026.
• The last three Other Operating Expenses figures came in at $30.1 million (Q1 2026), $29.4 million (Q4 2025), and $30.8 million (Q3 2025), per Business Quant data.

Peer Comparison